본문

  1. Home
6 Results:SS:GLUCOCORTICOID 0.46 sec.
RSS 
다국어입력
 상세검색
 신착검색
선택출력 선택엑셀내보내기
1
Serum NTX is a practical marker for assessing antiresorptive therapy for glucocorticoid treated patients with chronic kidney disease
Serum NTX is a practical marker for assessing antiresorptive therapy for glucocorticoid treated patients with chronic kidney disease
Takayuki Hamano., | Elsevier Inc | 2006 ,
2
Soluble glucocorticoid-induced tumor necrosis factor receptor stimulates osteoclastogenesis by down-regulation of osteoprotegerin in bone marrow stromal cells
Soluble glucocorticoid-induced tumor necrosis factor receptor stimulates osteoclastogenesis by down-regulation of osteoprotegerin in bone marrow stromal cells
Hyun-Hee Shin., | Elsevier Inc | 2006 ,
3
High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy : A cross-sectional outpatient study
High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy : A cross-sectional outpatient study
Alberto Angeli., | Elsevier Inc | 2006 ,
4
The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment
The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment
H. Oxlund., | Elsevier Inc | 2006 ,
5
Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells
Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells
E. L. Humphrey., | Elsevier Inc | 2006 ,
6
Corrigendum to "Inhibition of growth and differentiation of osteoprogenitors in mouse bone marrow stromal cell cultures by increased donor age and glucocorticoid treatment" [Bone 35 (2004) 83-95]
Corrigendum to "Inhibition of growth and differentiation of osteoprogenitors in mouse bone marrow stromal cell cultures by increased donor age and glucocorticoid treatment" [Bone 35 (2004) 83-95]
Theresa L. Chen., | Elsevier Inc | 2006 ,
처음1마지막